Pulmonary Hypertension | Norton Healthcare

Indication: Pulmonary Hypertension

A Randomized, Double-Blind, Placebo-Controlled Dose Escalation And Verification Clinical Study To Assess The Safety And Efficacy Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects At Risk Of Pulmonary Hypertension Associated With Pulmonary Fibrosis On Long Term Oxygen Therapy (Part 1 And Part 2)

Sub-indication: Pulmonary Arterial Hypertension

Study Type: Drug Study

Principal Investigator: John McConnell, M.D.
Norton Pulmonary Specialists

Sponsor: Sponsor: Bellerophon Pulse Technologies LLC

Learn more at ClinicalTrials.gov

Email for more information: npsresearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.